Literature DB >> 8795587

Forty years of repeated screening: the significance of carcinoma in situ.

B J Morrison1, A J Coldman, D A Boyes, G H Anderson.   

Abstract

Two cohorts of women born in 1914-18 and 1929-33 who participated in a cervical screening programme have been followed for over 40 years. Age-specific incidence rates of squamous carcinoma of the cervix by rank of smear and length of interval between smears are reported. The younger cohort, who had undergone more frequent screening, had lower rates of invasive disease. From these incidence rates, estimates of false-negative rates and regression rates for carcinoma in situ have been made. The false-negative rate was estimated to be about 15%. Regression seemed more frequent in younger than in older women. For the younger cohort it was estimated to be 72% and in the older 47%. A comparison of the rates of in situ carcinoma with those of invasive disease suggests that the screening of the younger cohort reduced the rate of invasive disease to at least one-half or one-third of what it would have been if screening had commenced later. Rates of disease appear less dependent on age than previously thought and are consistent with causation by an infective agent.

Entities:  

Mesh:

Year:  1996        PMID: 8795587      PMCID: PMC2074715          DOI: 10.1038/bjc.1996.441

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  Cancer of the cervix: a sexually transmitted infection?

Authors:  V Beral
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

2.  Cervical cancer detection in British Columbia. A progress report.

Authors:  H K Fidler; D A Boyes; A J Worth
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-04

3.  A cohort study of cervical cancer screening in British Columbia.

Authors:  D A Boyes; B Morrison; E G Knox; G J Draper; A B Miller
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

4.  Experience with cervical screening in British Columbia.

Authors:  D A Boyes; A J Worth; G H Anderson
Journal:  Gynecol Oncol       Date:  1981-10       Impact factor: 5.482

5.  "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study.

Authors:  C La Vecchia; S Franceschi; A Decarli; M Fasoli; A Gentile; G Tognoni
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

6.  A case-control study of cervical cancer screening in north east Scotland.

Authors:  J E Macgregor; S M Moss; D M Parkin; N E Day
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

7.  Natural history of cervical neoplasia: consistent results obtained by an identification technique.

Authors:  L Gustafsson; H O Adami
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

  7 in total
  5 in total

1.  Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.

Authors:  Alison S Rustagi; Aruna Kamineni; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2013-08-21       Impact factor: 4.897

Review 2.  Clinical application of DNA ploidy to cervical cancer screening: A review.

Authors:  David Garner
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.

Authors:  Andrew J Coldman; Lovedeep Gondara; Laurie W Smith; Dirk van Niekerk; Kathy Ceballos; Mel Krajden; Darrel Cook; David J Quinlan; Marette Lee; Gavin Ce Stuart; Stuart Peacock; Ruth Elwood Martin; Laura Gentile; Eduardo L Franco; Gina S Ogilvie
Journal:  Br J Cancer       Date:  2016-11-17       Impact factor: 7.640

4.  Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study.

Authors:  Julien Chevreau; Antonin Mercuzot; Arthur Foulon; Chirstophe Attencourt; Fabrice Sergent; Ségolène Lanta; Jean Gondry
Journal:  J Low Genit Tract Dis       Date:  2017-04       Impact factor: 1.925

5.  Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?

Authors:  R Marshall Austin; Agnieszka Onisko; Chengquan Zhao
Journal:  J Am Soc Cytopathol       Date:  2020-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.